113 related articles for article (PubMed ID: 21983442)
1. Synthesis and structure-activity relationship studies of dihydronaphthyridinediones as a novel structural class of potent and selective PDE7 inhibitors.
Gewald R; Rueger C; Grunwald C; Egerland U; Hoefgen N
Bioorg Med Chem Lett; 2011 Nov; 21(22):6652-6. PubMed ID: 21983442
[TBL] [Abstract][Full Text] [Related]
2. Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 1: design, synthesis and structure-activity relationship studies.
Vergne F; Bernardelli P; Lorthiois E; Pham N; Proust E; Oliveira C; Mafroud AK; Royer F; Wrigglesworth R; Schellhaas J; Barvian M; Moreau F; Idrissi M; Tertre A; Bertin B; Coupe M; Berna P; Soulard P
Bioorg Med Chem Lett; 2004 Sep; 14(18):4607-13. PubMed ID: 15324874
[TBL] [Abstract][Full Text] [Related]
3. Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson's disease model.
Banerjee A; Patil S; Pawar MY; Gullapalli S; Gupta PK; Gandhi MN; Bhateja DK; Bajpai M; Sangana RR; Gudi GS; Khairatkar-Joshi N; Gharat LA
Bioorg Med Chem Lett; 2012 Oct; 22(19):6286-91. PubMed ID: 22944118
[TBL] [Abstract][Full Text] [Related]
4. Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 1.
Lorthiois E; Bernardelli P; Vergne F; Oliveira C; Mafroud AK; Proust E; Heuze L; Moreau F; Idrissi M; Tertre A; Bertin B; Coupe M; Wrigglesworth R; Descours A; Soulard P; Berna P
Bioorg Med Chem Lett; 2004 Sep; 14(18):4623-6. PubMed ID: 15324876
[TBL] [Abstract][Full Text] [Related]
5. Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferation.
Guo J; Watson A; Kempson J; Carlsen M; Barbosa J; Stebbins K; Lee D; Dodd J; Nadler SG; McKinnon M; Barrish J; Pitts WJ
Bioorg Med Chem Lett; 2009 Apr; 19(7):1935-8. PubMed ID: 19272774
[TBL] [Abstract][Full Text] [Related]
6. Discovery and SAR study of 2-(4-pyridylamino)thieno[3,2-d]pyrimidin-4(3H)-ones as soluble and highly potent PDE7 inhibitors.
Endo Y; Kawai K; Asano T; Amano S; Asanuma Y; Sawada K; Ogura K; Nagata N; Ueo N; Takahashi N; Sonoda Y; Kamei N
Bioorg Med Chem Lett; 2015 Feb; 25(3):649-53. PubMed ID: 25529739
[TBL] [Abstract][Full Text] [Related]
7. Identification of purine inhibitors of phosphodiesterase 7 (PDE7).
Pitts WJ; Vaccaro W; Huynh T; Leftheris K; Roberge JY; Barbosa J; Guo J; Brown B; Watson A; Donaldson K; Starling GC; Kiener PA; Poss MA; Dodd JH; Barrish JC
Bioorg Med Chem Lett; 2004 Jun; 14(11):2955-8. PubMed ID: 15125967
[TBL] [Abstract][Full Text] [Related]
8. Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 2: metabolism-directed optimization studies towards orally bioavailable derivatives.
Vergne F; Bernardelli P; Lorthiois E; Pham N; Proust E; Oliveira C; Mafroud AK; Ducrot P; Wrigglesworth R; Berlioz-Seux F; Coleon F; Chevalier E; Moreau F; Idrissi M; Tertre A; Descours A; Berna P; Li M
Bioorg Med Chem Lett; 2004 Sep; 14(18):4615-21. PubMed ID: 15324875
[TBL] [Abstract][Full Text] [Related]
9. Unraveling phosphodiesterase surfaces. Identification of phosphodiesterase 7 allosteric modulation cavities.
Redondo M; Soteras I; Brea J; González-García A; Cadavid MI; Loza MI; Martinez A; Gil C; Campillo NE
Eur J Med Chem; 2013; 70():781-8. PubMed ID: 24239625
[TBL] [Abstract][Full Text] [Related]
10. Microwave-assisted synthesis of potent PDE7 inhibitors containing a thienopyrimidin-4-amine scaffold.
Sánchez AI; Meneses R; Mínguez JM; Núñez A; Castillo RR; Filace F; Burgos C; Vaquero JJ; Álvarez-Builla J; Cortés-Cabrera A; Gago F; Terricabras E; Segarra V
Org Biomol Chem; 2014 Jun; 12(24):4233-42. PubMed ID: 24838636
[TBL] [Abstract][Full Text] [Related]
11. Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure-activity relationships.
Kempson J; Pitts WJ; Barbosa J; Guo J; Omotoso O; Watson A; Stebbins K; Starling GC; Dodd JH; Barrish JC; Felix R; Fischer K
Bioorg Med Chem Lett; 2005 Apr; 15(7):1829-33. PubMed ID: 15780616
[TBL] [Abstract][Full Text] [Related]
12. PDE7-Selective and Dual Inhibitors: Advances in Chemical and Biological Research.
Jankowska A; Swierczek A; Chlon-Rzepa G; Pawlowski M; Wyska E
Curr Med Chem; 2017; 24(7):673-700. PubMed ID: 28093982
[TBL] [Abstract][Full Text] [Related]
13. Isothiazole and isoxazole fused pyrimidones as PDE7 inhibitors: SAR and pharmacokinetic evaluation.
Banerjee A; Yadav PS; Bajpai M; Sangana RR; Gullapalli S; Gudi GS; Gharat LA
Bioorg Med Chem Lett; 2012 May; 22(9):3223-8. PubMed ID: 22487174
[TBL] [Abstract][Full Text] [Related]
14. Discovery and SAR of novel, potent and selective hexahydrobenzonaphthyridinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
Torrisi C; Bisbocci M; Ingenito R; Ontoria JM; Rowley M; Schultz-Fademrecht C; Toniatti C; Jones P
Bioorg Med Chem Lett; 2010 Jan; 20(2):448-52. PubMed ID: 20015648
[TBL] [Abstract][Full Text] [Related]
15. Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK).
Cywin CL; Zhao BP; McNeil DW; Hrapchak M; Prokopowicz AS; Goldberg DR; Morwick TM; Gao A; Jakes S; Kashem M; Magolda RL; Soll RM; Player MR; Bobko MA; Rinker J; DesJarlais RL; Winters MP
Bioorg Med Chem Lett; 2003 Apr; 13(8):1415-8. PubMed ID: 12668002
[TBL] [Abstract][Full Text] [Related]
16. Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compounds.
Redondo M; Brea J; Perez DI; Soteras I; Val C; Perez C; Morales-García JA; Alonso-Gil S; Paul-Fernandez N; Martin-Alvarez R; Cadavid MI; Loza MI; Perez-Castillo A; Mengod G; Campillo NE; Martinez A; Gil C
J Med Chem; 2012 Apr; 55(7):3274-84. PubMed ID: 22385507
[TBL] [Abstract][Full Text] [Related]
17. 2-(Isopropylamino)thieno[3,2-d]pyrimidin-4(3H)-one derivatives as selective phosphodiesterase 7 inhibitors with potent in vivo efficacy.
Endo Y; Kawai K; Asano T; Amano S; Asanuma Y; Sawada K; Onodera Y; Ueo N; Takahashi N; Sonoda Y; Kamei N; Irie T
Bioorg Med Chem Lett; 2015 May; 25(9):1910-4. PubMed ID: 25866242
[TBL] [Abstract][Full Text] [Related]
18. Discovery of triazines as potent, selective and orally active PDE4 inhibitors.
Gewald R; Grunwald C; Egerland U
Bioorg Med Chem Lett; 2013 Aug; 23(15):4308-14. PubMed ID: 23806553
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model.
Redondo M; Zarruk JG; Ceballos P; Pérez DI; Pérez C; Perez-Castillo A; Moro MA; Brea J; Val C; Cadavid MI; Loza MI; Campillo NE; Martínez A; Gil C
Eur J Med Chem; 2012 Jan; 47(1):175-85. PubMed ID: 22100138
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological screening, and molecular docking of quinazolinone and quinazolinethione as phosphodiesterase 7 inhibitors.
Elfeky SM; Sobahi TR; Gineinah MM; Ahmed NS
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900211. PubMed ID: 31696968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]